Results 171 to 180 of about 495,856 (271)
Transfusion Thresholds and Neurological Functional Outcome After Acute Brain Injury: An Updated Systematic Review and Meta-Analysis of Randomized Clinical Trials [PDF]
Pierludovico Moro +6 more
openalex +1 more source
Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 11
, 2023 openalex +1 more source
Reduced Muscular Carnosine in Proximal Myotonic Myopathy—A Pilot 1H‐MRS Study
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Myotonic dystrophy type 2 (proximal myotonic myopathy, PROMM) is a progressive multisystem disorder with muscular symptoms (proximal weakness, pain, myotonia) and systemic manifestations such as diabetes mellitus, cataracts, and cardiac arrhythmias.
Alexander Gussew +11 more
wiley +1 more source
Handbook of Clinical Neurology: Neonatal Neurology, Volume 162, 1st edition
Listy klinicke logopedie, 2020 Barbora Červenková
doaj
Changing the Brain, Changing the Society: Clinical and Ethical Implications of Neuromodulation Techniques in Neurology and Psychiatry [PDF]
, 2013 Patrik Vuilleumier +2 more
openalex +1 more source
Acoustic Measures Capture Speech Dysfunction in Spinocerebellar Ataxia
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Spinocerebellar ataxias (SCA) are hereditary cerebellar degenerative disorders with a common feature of dysarthria, involving impaired phonatory and articulatory control of speech, thereby affecting social communication. In this study, we investigated whether acoustic measures could objectively measure speech dysfunction and identify
Zena Fadel +5 more
wiley +1 more source
The emergence of single neurons in clinical neurology. [PDF]
Neuron, 2015 Cash SS, Hochberg LR.
europepmc +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune‐mediated neuropathy featuring progressive weakness, sensory deficits, and areflexia. While corticosteroids, intravenous immunoglobulin, and plasmapheresis are effective first‐line immunotherapies, a subset of patients remains treatment‐refractory.
Xueyu Zhang +8 more
wiley +1 more source